Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment Options
Clinical trial NCT03825484 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03825484
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.